Treats infections due to susceptible isolates of the designated bacteria in the…. NDA 50725, held by US Antibiotics. Amoxicillin; Clavulanate Potassium.
As of Nov 13, 2026, NDA 50725 (Augmentin '200', Augmentin '400'), held by US Antibiotics, was first approved by FDA on May 31, 1996, with 32 approved supplements and 0 published complete response letters.
To reduce the development of drug‑resistant bacteria and maintain the effectiveness of Amoxicillin and Clavulanate Potassium and other antibacterial drugs, Amoxicillin and Clavulanate Potassium should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 31, 1996 | Original applicationNew dosage form · Standard review | Approved | None posted |
| Augmentin '200'200MG/5ML;EQ 28.5MG BASE/5ML · for suspension;oral | Amoxicillin; Clavulanate Potassium | DiscontinuedReference drug |
| Augmentin '400'400MG/5ML;EQ 57MG BASE/5ML · for suspension;oral | Amoxicillin; Clavulanate Potassium | DiscontinuedReference drug |
| Jul 17, 2026 | Supplement 37Labeling · Standard review | Approved | |
| May 1, 2024 | Supplement 36Labeling · Standard review | Approved | |
| Aug 25, 2022 | Supplement 35Labeling · Standard review | Approved | |
| Apr 17, 2015 | Supplement 34Manufacturing · Standard review | Approved | None posted |
| Sep 30, 2014 | Supplement 32Manufacturing · Standard review | Approved | None posted |
| Jan 22, 2013 | Supplement 30Labeling | Approved | |
| Jan 22, 2013 | Supplement 28Labeling · Standard review | Approved | |
| Sep 29, 2011 | Supplement 27Labeling · Standard review | Approved | |
| Dec 4, 2008 | Supplement 25Labeling · Standard review | Approved | |
| Mar 27, 2008 | Supplement 26Labeling · Standard review | Approved | |
| Aug 11, 2004 | Supplement 24Labeling · Standard review | Approved | |
| Jun 3, 2004 | Supplement 23Labeling · Standard review | Approved | |
| Dec 23, 2003 | Supplement 22 | Approved | |
| Jun 13, 2003 | Supplement 21 | Approved | |
| May 12, 2003 | Supplement 17Labeling · Standard review | Approved | |
| Dec 4, 2002 | Supplement 18Manufacturing · Standard review | Approved | None posted |
| Nov 27, 2002 | Supplement 15Manufacturing · Standard review | Approved | None posted |
| Oct 17, 2002 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Oct 7, 2002 | Supplement 19Manufacturing · Standard review | Approved | None posted |
| Apr 10, 2002 | Supplement 4Labeling · Standard review | Approved | |
| Dec 7, 2001 | Supplement 14Manufacturing · Standard review | Approved | |
| May 3, 2001 | Supplement 10Manufacturing · Standard review | Approved | |
| Apr 17, 2001 | Supplement 13Manufacturing · Standard review | Approved | |
| Mar 7, 2001 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Nov 27, 2000 | Supplement 11Manufacturing · Standard review | Approved | |
| Jun 8, 2000 | Supplement 8Manufacturing · Standard review | Approved | |
| Nov 19, 1999 | Supplement 7Manufacturing · Standard review | Approved | |
| Sep 23, 1999 | Supplement 6Manufacturing · Standard review | Approved | |
| Feb 1, 1999 | Supplement 5Manufacturing · Standard review | Approved | |
| Feb 19, 1998 | Supplement 3Manufacturing · Standard review | Approved | |
| Feb 11, 1998 | Supplement 2Labeling · Standard review | Approved | None posted |
| Mar 19, 1997 | Supplement 1Labeling · Standard review | Approved | None posted |
| May 31, 1996 | Original applicationNew dosage form · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters